EPISODE · Oct 14, 2024 · 6 MIN
Effect of Semaglutide on Cardiac Structure and Function in Patients with Obesity-Related Heart Failure
from JACC This Week
In the October 22, 2024 issue of JACC, a podcast explores the promising benefits of semaglutide, a glucagon-like peptide receptor agonist, in treating obesity-related heart failure. The episode discusses key findings from original research, highlighting how semaglutide improves cardiac structure and function, attenuates adverse remodeling, and showcases the dual mechanisms—both weight-related and independent—behind these effects.
NOW PLAYING
Effect of Semaglutide on Cardiac Structure and Function in Patients with Obesity-Related Heart Failure
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 3, 2026 ·44m
Feb 21, 2026 ·30m
Jan 2, 2026 ·47m